NASDAQ:ZYXI Zynex (ZYXI) Stock Price, News & Analysis $7.66 -0.11 (-1.42%) As of 01/14/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Zynex Stock (NASDAQ:ZYXI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Zynex alerts:Sign Up Key Stats Today's Range$7.50▼$7.8650-Day Range$7.66▼$9.3052-Week Range$7.15▼$13.77Volume91,264 shsAverage Volume63,021 shsMarket Capitalization$243.94 millionP/E Ratio51.07Dividend YieldN/APrice Target$14.00Consensus RatingBuy Company OverviewZynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Read More… Zynex Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks74th Percentile Overall ScoreZYXI MarketRank™: Zynex scored higher than 74% of companies evaluated by MarketBeat, and ranked 307th out of 955 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingZynex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageZynex has only been the subject of 1 research reports in the past 90 days.Read more about Zynex's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth135.00% Earnings GrowthEarnings for Zynex are expected to grow by 135.00% in the coming year, from $0.20 to $0.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zynex is 51.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 109.47.Price to Earnings Ratio vs. SectorThe P/E ratio of Zynex is 51.07, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.82.Price to Book Value per Share RatioZynex has a P/B Ratio of 5.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted26.90% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 51.5, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently decreased by 2.97%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldZynex does not currently pay a dividend.Dividend GrowthZynex does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted26.90% of the float of Zynex has been sold short.Short Interest Ratio / Days to CoverZynex has a short interest ratio ("days to cover") of 51.5, which indicates bearish sentiment.Change versus previous monthShort interest in Zynex has recently decreased by 2.97%, indicating that investor sentiment is improving. News and Social Media2.3 / 5News SentimentN/A News SentimentZynex has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Zynex this week, compared to 2 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Zynex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $368,040.00 in company stock.Percentage Held by Insiders52.13% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 29.68% of the stock of Zynex is held by institutions.Read more about Zynex's insider trading history. Receive ZYXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter. Email Address ZYXI Stock News HeadlinesInsider Selling: Zynex, Inc. (NASDAQ:ZYXI) CFO Sells 10,000 Shares of StockJanuary 4, 2025 | insidertrades.comZynex (ZYXI) Gets a Buy from RBC CapitalDecember 20, 2024 | markets.businessinsider.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.January 15, 2025 | Crypto Swap Profits (Ad)An Intrinsic Calculation For Zynex, Inc. (NASDAQ:ZYXI) Suggests It's 22% UndervaluedDecember 18, 2024 | uk.finance.yahoo.comZynex partners with VA to offer pain management solutions for veteransDecember 17, 2024 | proactiveinvestors.comZynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United StatesDecember 17, 2024 | prnewswire.comZynex CEO outlines plans for 2025 after revenue milestone – ICYMIDecember 13, 2024 | proactiveinvestors.comZynex CEO outlines plans for 2025 after revenue milestone – ICYMIDecember 13, 2024 | proactiveinvestors.comSee More Headlines ZYXI Stock Analysis - Frequently Asked Questions How have ZYXI shares performed this year? Zynex's stock was trading at $8.01 at the beginning of 2025. Since then, ZYXI shares have decreased by 4.4% and is now trading at $7.66. View the best growth stocks for 2025 here. How were Zynex's earnings last quarter? Zynex, Inc. (NASDAQ:ZYXI) issued its quarterly earnings results on Thursday, October, 24th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.01. The firm's revenue was up .1% compared to the same quarter last year. How do I buy shares of Zynex? Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Zynex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zynex investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AUO (AUOTY) and Humana (HUM). Company Calendar Last Earnings10/24/2024Today1/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:ZYXI CUSIPN/A CIK846475 Webwww.zynex.com Phone(303) 703-4906FaxN/AEmployees1,100Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$17.00 Low Stock Price Target$11.00 Potential Upside/Downside+82.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.15 Trailing P/E Ratio51.07 Forward P/E Ratio38.30 P/E GrowthN/ANet Income$9.73 million Net Margins2.49% Pretax Margin3.48% Return on Equity13.05% Return on Assets3.78% Debt Debt-to-Equity Ratio1.66 Current Ratio3.94 Quick Ratio3.15 Sales & Book Value Annual Sales$193.67 million Price / Sales1.26 Cash Flow$0.39 per share Price / Cash Flow19.78 Book Value$1.36 per share Price / Book5.63Miscellaneous Outstanding Shares31,846,000Free Float15,245,000Market Cap$243.94 million OptionableOptionable Beta0.53 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report This page (NASDAQ:ZYXI) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.